We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+14.65%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.2B
AUM Growth
+$1.36B
Cap. Flow
+$247M
Cap. Flow %
2.41%
Top 10 Hldgs %
41.78%
Holding
993
New
160
Increased
389
Reduced
300
Closed
137

Sector Composition

Rank Sector Weight
1 Energy 49.58%
2 Financials 10.59%
3 Technology 7.11%
4 Healthcare 5.04%
5 Industrials 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
401
Tectonic Therapeutic
TECX
$578M
$952K 0.01%
6,250
+761
+14% +$124K
ALXN
402
DELISTED
Alexion Pharmaceuticals
ALXN
$952K 0.01%
6,226
-1,029
-14% -$159K
ALT icon
403
Altimmune
ALT
$576M
$950K 0.01%
67,200
+7,725
+13% +$125K
AOS icon
404
A.O. Smith
AOS
$8.61B
$919K 0.01%
13,594
+3,916
+40% +$238K
CRNX icon
405
Crinetics Pharmaceuticals
CRNX
$8.87B
$910K 0.01%
59,563
+126
+0.2% +$1.95K
XBIT icon
406
XBiotech
XBIT
$68.9M
$909K 0.01%
52,932
+534
+1% +$9.97K
MPWR icon
407
Monolithic Power Systems
MPWR
$65.8B
$907K 0.01%
2,568
-402
-14% -$146K
ENTG icon
408
Entegris
ENTG
$19.2B
$897K 0.01%
8,016
-1,745
-18% -$180K
GERN icon
409
Geron
GERN
$949M
$888K 0.01%
561,717
+545
+0.1% +$973
STWD icon
410
Starwood Property Trust
STWD
$6.15B
$885K 0.01%
35,756
-5,292
-13% -$115K
RNAC icon
411
Cartesian Therapeutics
RNAC
$229M
$884K 0.01%
6,515
+120
+2% +$14.9K
WRK
412
DELISTED
WestRock Company
WRK
$880K 0.01%
16,907
-3,047
-15% -$142K
FNB icon
413
FNB Corp
FNB
$6.71B
$878K 0.01%
69,142
-10,230
-13% -$118K
GMDA
414
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$866K 0.01%
107,107
+17,686
+20% +$162K
ETNB
415
DELISTED
89bio
ETNB
$852K 0.01%
35,959
+28
+0.1% +$646
EPAM icon
416
EPAM Systems
EPAM
$4.92B
$850K 0.01%
2,141
-164
-7% -$60K
PGRE
417
DELISTED
Paramount Group
PGRE
$847K 0.01%
83,632
-12,376
-13% -$116K
GGG icon
418
Graco
GGG
$13B
$841K 0.01%
11,742
+3,201
+37% +$227K
AAT
419
American Assets Trust
AAT
$1.49B
$840K 0.01%
25,904
-3,834
-13% -$119K
VKTX icon
420
Viking Therapeutics
VKTX
$4.05B
$835K 0.01%
131,978
+469
+0.4% +$3.3K
ALDX icon
421
Aldeyra Therapeutics
ALDX
$95.3M
$834K 0.01%
70,227
+1,057
+2% +$12.2K
SYRS
422
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$834K 0.01%
11,151
+2,880
+35% +$299K
DEI icon
423
Douglas Emmett
DEI
$2.03B
$780K 0.01%
24,851
-4,518
-15% -$138K
CCI icon
424
Crown Castle
CCI
$32.4B
$778K 0.01%
4,522
+495
+12% +$79.3K
CTAS icon
425
Cintas
CTAS
$84.4B
$777K 0.01%
9,108
-588
-6% -$49.8K

Similar funds

ALPS Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, ALPS Advisors held 993 positions worth $10.2B, up 15% from $8.88B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

ALPS Advisors's Q1 2021 filing shows 160 new, 389 increased, 300 reduced and 137 closed positions. Its largest new stake was Array Technologies: 823,364 shares worth $24.6M. The largest sale was TC Pipelines LP, an estimated $179M.

By sector, the portfolio is most concentrated in Energy at 50% of assets, up from 48% a quarter earlier, followed by Financials and Technology.

  • ALPS Advisors's largest Q1 2021 buy was Array Technologies: 823,364 shares worth $24.6M.
  • ALPS Advisors added most to Magellan Midstream Partners, L.P. in Q1 2021, an estimated $70.7M increase.
  • ALPS Advisors's biggest Q1 2021 reduction was Caterpillar, cutting an estimated $40.8M.
  • ALPS Advisors fully exited TC Pipelines LP in Q1 2021, selling an estimated $179M.
  • ALPS Advisors's ten largest holdings make up 42% of its $10.2B portfolio in Q1 2021.
  • ALPS Advisors opened 160 new positions and closed 137 in Q1 2021.
  • ALPS Advisors's portfolio value rose 15% quarter-over-quarter to $10.2B.

Based on ALPS Advisors's 13F filing for Q1 2021, filed 7 May 2021.